Malaria treatment study in Ethiopia
Part of Infections clinical trials.
This study tests how well malaria treatments work in Ethiopia. It aims to find the best medicines for uncomplicated malaria caused by certain parasites, helping patients recover fully and preventing future drug resistance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 6 months old.
- You weigh at least 5 kilograms.
- You tested positive for malaria (either Plasmodium falciparum or Plasmodium vivax) with a confirmed blood test.
- You have a fever or experienced one in the last 24 hours.
- You live within 20 kilometers of the study clinic or in the defined study area and plan to stay there during the study.
- You do not have severe anemia, malnutrition, or other serious medical conditions.
- If you are a woman of childbearing age (12-49), you agree to take a pregnancy test and use effective contraception during the study.
- You can swallow oral medication and give your consent (or have a parent or guardian consent for you).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a blood test to find and treat people infected with a type of malaria called Plasmodium vivax can reduce the spread of the disease. It may help you and your community stay healthier.
This study compares a combination of three medicines to treat uncomplicated malaria, to see if it works as well and is as well tolerated as a two-medicine combination. You may join if you have a specific type of malaria infection in a mild form and meet safety requirements.
This trial studies how well and how safely different anti-malaria medicines work for people who have uncomplicated malaria caused by Plasmodium falciparum. You may be eligible if you have a confirmed infection with a certain parasite level and do not have signs of severe disease or major health conditions.
This trial tests a medicine called tafenoquine, which is used to treat malaria. It aims to see how well it works in children with uncomplicated malaria, and participants will also receive standard malaria treatments.
This study tests how well a malaria treatment plan works for people with P. vivax malaria who don’t have another malaria type at the same time. It aims to see whether adding or using different medicines (ACT vs chloroquine with tafenoquine) helps clear infection and prevent return of disease.
This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.
Hear when a new Plasmodium Vivax Malaria Without Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.